Active — Not RecruitingNot Applicable

Program to Avoid NSAIDs in Patients With Advanced Chronic Liver Disease

Spain84 participantsStarted 2023-04-01

Plain-language summary

This study aims to implement measures to avoid the use of NSAIDs or metamizole in patients with advanced chronic liver disease (ACLD) scheduled for major surgery, which are contraindicated due to increased risk of renal dysfunction such as acute kidney injury (AKI), clinical decompensation such as ascites, and bleeding.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Adults (\>18 years) with ACLD scheduled for major surgery * Exclusion Criteria: Absence of ACLD or portal hypertension, lack of informed consent

What they're measuring

NSAIDs/metamizole prescription

Timeframe: 180 days

Trial details

NCT IDNCT07249294

SponsorParc de Salut Mar

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-12-31

View on ClinicalTrials.gov More Advanced Chronic Liver Disease trials